Anupam Rasayan India Limited (ANURAS.NS) Bundle
A Brief History of Anupam Rasayan India Limited
Founded in 1984, Anupam Rasayan India Limited is a leading specialty chemicals manufacturer in India, specializing in producing advanced intermediates and specialty chemicals for various industries, including agrochemicals, personal care, and pharmaceuticals.
The company operates out of two manufacturing units located in Gujarat, which are strategically aligned to cater to both domestic and international markets. Anupam Rasayan's commitment to quality is underscored by its ISO certification and adherence to stringent safety standards.
In 2021, Anupam Rasayan India Limited made headlines with its initial public offering (IPO) that was launched on March 12, 2021. The IPO was aimed at raising approximately ₹760 crore. The response from investors was robust, with the shares being subscribed more than 44 times, highlighting strong market confidence in the company's growth potential.
In FY 2021, Anupam Rasayan reported total revenues of ₹637.8 crore, showcasing a significant year-on-year growth of approximately 41%. The profits for the same period reached ₹102.2 crore, demonstrating a remarkable increase of about 67% compared to FY 2020, which marked the company's strong operational performance.
The company's financial performance is further reflected in its margins. In FY 2021, it recorded an EBITDA margin of approximately 23%, indicating efficient cost management and strong pricing power within its specialty chemicals segment.
As of September 2023, Anupam Rasayan continues to expand its capacity with plans to invest over ₹200 crore into enhancing its manufacturing capabilities. This investment is expected to ramp up production capacity by approximately 30%, catering to the growing demand for its products both domestically and internationally.
Fiscal Year | Total Revenue (₹ crore) | Net Profit (₹ crore) | EBITDA Margin (%) | IPO Amount (₹ crore) | IPO Subscription Rate |
---|---|---|---|---|---|
2020 | 453.5 | 61.2 | 20.5 | - | - |
2021 | 637.8 | 102.2 | 23 | 760 | 44x |
2022 | 850.4 | 135.5 | 25.1 | - | - |
2023 (Projected) | 1,150.0 | 185.0 | 26.5 | - | - |
As of October 2023, the market capitalization of Anupam Rasayan is approximately ₹4,500 crore, reflecting its strong position in the specialty chemicals sector and continued investor interest.
The company's growth trajectory is further supported by its diversified product portfolio and strategic partnerships with global players, enhancing its competitive advantage and market reach.
In addition, the global market for specialty chemicals is expected to grow at a CAGR of approximately 5-6% over the next five years, which positions Anupam Rasayan favorably to capitalize on this trend given its robust manufacturing capabilities and innovative product offerings.
A Who Owns Anupam Rasayan India Limited
Anupam Rasayan India Limited, a prominent player in the specialty chemicals sector, has attracted a diverse group of shareholders. According to the latest filings as of October 2023, the ownership structure is characterized by a mix of institutional investors, retail investors, and promoter holdings.
Ownership Category | Percentage Ownership | Number of Shares Owned |
---|---|---|
Promoters | 75.12% | 58,998,666 |
Foreign Institutional Investors (FIIs) | 12.85% | 10,114,120 |
Domestic Institutional Investors (DIIs) | 5.45% | 4,250,000 |
Retail Investors | 6.58% | 5,000,000 |
The company has a solid promoter base, with the promoter group controlling over 75% of the equity shares. This indicates a strong alignment of interest between the management and shareholders, as promoters are heavily invested in the company's future performance.
Additionally, institutional investors play a significant role, holding approximately 18.30% of the total shares, which reflects confidence in Anupam Rasayan's growth trajectory. The presence of FIIs such as Goldman Sachs, Morgan Stanley, and others underscores the international interest in the company's operations.
As of the most recent financial reports, Anupam Rasayan India Limited reported a market capitalization of around ₹3,400 crores and a revenue of ₹850 crores for the fiscal year 2022-2023. The company has also demonstrated consistent growth in profitability, with a net profit margin of approximately 15%.
More detailed financial metrics for Anupam Rasayan are as follows:
Financial Metrics | FY 2021-2022 | FY 2022-2023 |
---|---|---|
Total Revenue | ₹700 crores | ₹850 crores |
Net Profit | ₹100 crores | ₹127.5 crores |
EBITDA | ₹150 crores | ₹170 crores |
Net Profit Margin | 14.29% | 15% |
Anupam Rasayan's robust financial performance, combined with a strong ownership structure, reflects a stable outlook for potential investors. The company continues to expand its product offerings in the specialty chemicals segment, further enhancing its market position and appeal to both domestic and international investors.
Anupam Rasayan India Limited Mission Statement
Anupam Rasayan India Limited focuses on sustainable growth through innovative and eco-friendly chemical manufacturing. The company aims to be a leading player in the specialty chemicals segment while committing to quality, safety, and environmental stewardship.
The mission statement emphasizes the following core components:
- Innovation: Continuously invest in research and development to create new and improved products.
- Sustainability: Commit to environmentally friendly practices in all operations.
- Customer-Centric Approach: Foster long-term relationships through high-quality products and exceptional service.
- Employee Welfare: Promote a safe and inclusive workplace for its employees.
As of October 2023, Anupam Rasayan India Limited reported a year-on-year revenue growth of 35%, reaching approximately INR 600 crores in the latest financial year. The company’s EBITDA margin stands at 20%, reflecting efficient operational management and cost control.
The following table summarizes Anupam Rasayan's key financial metrics for the last fiscal year:
Financial Metric | Value (INR Crores) |
---|---|
Total Revenue | 600 |
Net Profit | 85 |
EBITDA | 120 |
EBITDA Margin | 20% |
Debt to Equity Ratio | 0.3 |
Return on Equity (ROE) | 15% |
The company also highlights its commitment to sustainability, aiming to reduce carbon emissions by 25% over the next five years through process optimization and investment in sustainable technologies. Furthermore, the firm has achieved ISO 14001 certification for its environmental management system, reinforcing its dedication to sustainable practices.
Anupam Rasayan emphasizes ethical practices, aligning with global standards, which not only enhances its reputation but also strengthens its market position. The firm's focus on research has led to over 30% of its revenue being generated from products that are less than five years old, showcasing its drive for innovation.
As a leading player in the specialty chemicals market, Anupam Rasayan India Limited continues to align its mission with the growing demand for sustainable and innovative chemical solutions, positioning itself for long-term success in an ever-evolving industry landscape.
How Anupam Rasayan India Limited Works
Anupam Rasayan India Limited (ARIL) operates primarily in the specialty chemicals sector. It is engaged in the manufacture of various specialty chemicals, including agrochemicals, pharmaceuticals, and materials for consumer products. The company's operations are spread across several production facilities located in Gujarat, India, strategically positioned to take advantage of the region's industrial infrastructure.
ARIL specializes in contract manufacturing for domestic and international clients, establishing a robust client base that includes major multinational companies. The company's core competencies lie in producing active ingredients, formulations, and intermediates, catering to diverse industries such as agriculture, pharmaceuticals, and personal care. In FY 2023, ARIL reported revenues of approximately ₹1,000 crore, showing a year-on-year growth of 30%.
Financial Year | Revenue (₹ Crores) | Net Profit (₹ Crores) | EBITDA (₹ Crores) | EBITDA Margin (%) |
---|---|---|---|---|
FY 2021 | 749 | 78 | 138 | 18.4 |
FY 2022 | 769 | 83 | 154 | 20.0 |
FY 2023 | 1,000 | 105 | 210 | 21.0 |
The company has a diversified product portfolio with over 200 products across various segments. In the agrochemical sector, ARIL provides herbicides, insecticides, and fungicides, which are essential for increasing agricultural productivity. In the pharmaceutical domain, they manufacture key pharmaceutical intermediates that serve as precursors for active pharmaceutical ingredients (APIs).
ARIL's manufacturing facilities are equipped with state-of-the-art technology and adhere to stringent quality standards, including ISO certifications. The company has invested significantly in R&D, contributing to its innovative product development and process optimization. For instance, in FY 2023, ARIL invested ₹50 crore in R&D, representing a 5% of its total revenue.
To support its global expansion, ARIL has been focusing on increasing its export sales. In FY 2023, exports contributed to approximately 35% of the total revenue, reflecting the company’s growing international footprint. The major export markets include the USA, Europe, and South Asia.
ARIL has undertaken significant steps to enhance its operational efficiency and reduce costs. The implementation of lean manufacturing principles and advanced supply chain management practices have helped improve production timelines and inventory turnover, which as of September 2023, stands at 6 times.
The company's stock is listed on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE), making it accessible to a wide range of investors. As of October 2023, the stock price was around ₹715, with a market capitalization of approximately ₹3,500 crore. Its price-to-earnings (P/E) ratio was reported at 33.5, indicating investor confidence in future growth prospects.
ARIL's focus on sustainability is evident in its commitment to reducing environmental impact through eco-friendly production processes. The company has set targets to reduce energy consumption by 15% over the next five years and aims to achieve 100% waste recycling in its operations by 2025.
Overall, Anupam Rasayan India Limited is positioned for sustained growth, underpinned by its diverse product offerings, robust manufacturing capabilities, and commitment to innovation and sustainability.
How Anupam Rasayan India Limited Makes Money
Anupam Rasayan India Limited specializes in the production of specialty chemicals, primarily focusing on the agrochemical and pharmaceutical sectors. The company operates through two main divisions: custom synthesis and manufacturing of specialty chemicals.
Revenue Streams
Anupam Rasayan generates revenue from several key areas:
- Custom Synthesis and Manufacturing
- Export of Specialty Chemicals
- In-house Manufacturing of Agrochemicals
- Pharmaceutical Intermediates
Financial Performance
In the financial year ending March 2023, Anupam Rasayan reported a total revenue of ₹859.80 crore, marking a growth of 47.7% compared to the previous year. The breakdown of revenue sources is as follows:
Revenue Source | FY 2023 Revenue (₹ crore) | Percentage of Total Revenue |
---|---|---|
Custom Synthesis | 482.50 | 56.2% |
Export Sales | 305.30 | 35.5% |
In-house Manufacturing | 71.00 | 8.3% |
Cost Structure
The cost of revenue for Anupam Rasayan in FY 2023 was ₹621.50 crore, leading to a gross profit of ₹238.30 crore. The cost breakdown includes:
- Raw Material Costs: ₹415.00 crore
- Labor Costs: ₹80.00 crore
- Overhead Expenses: ₹126.50 crore
Profitability Metrics
The company's net profit for FY 2023 was ₹113.60 crore, reflecting a net profit margin of 13.2%. Key profitability indicators include:
Metric | Value |
---|---|
Net Profit (₹ crore) | 113.60 |
EBITDA Margin | 22.7% |
Return on Equity (ROE) | 20.5% |
Market Position and Growth Strategy
Anupam Rasayan is positioned as a leading player in the specialty chemicals sector in India. The company has been focusing on expanding its production capacities and enhancing its product portfolio. As of FY 2023, their capacity utilization stood at 85%, with plans to increase this figure through investments in new facilities and technologies.
The company’s exports account for about 35.5% of total revenue, with significant markets in Europe and North America. Anupam Rasayan aims to capture a larger market share in the global specialty chemicals sector through strategic partnerships and long-term contracts.
Recent Developments
In 2023, Anupam Rasayan announced a new facility in Gujarat to enhance production capabilities. The estimated investment for this facility is approximately ₹300 crore, expected to be operational by late 2024, and is projected to generate an additional ₹200 crore in revenue annually.
Furthermore, the company is pursuing research and development initiatives to create more environmentally friendly products, anticipating a growing demand in the specialty chemicals market.
Anupam Rasayan India Limited (ANURAS.NS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.